TRexBio Closes $84M Series B to Advance Immune-Based Therapeutics
Key Highlights TRexBio raises $84M in Series B led by Delos Capital with new investors Avego BioScience and Agent…
Browsing Tag
Alexandria Venture Investments
8 posts
Judo Bio Secures $100M Financing to Advance Kidney-Targeted Oligonucleotide Medicines
Key Highlights Judo Bio secures $100M in initial financing for kidney-targeted medicines. Series A co-led by Atlas Venture, TCG, and…
858 Therapeutics Secures $50M Series B Financing to Advance Oncology Therapeutics
Key Highlights 858 Therapeutics raises $50M in Series B financing led by Avidity Partners. Proceeds to advance ETX-19477, a selective…
AIRNA Closes $60M Series A Round to Advance RNA Editing Therapeutics
Key Highlights AIRNA secures $60M in oversubscribed Series A financing. Funding led by Forbion with key investments from…
TwoStep Therapeutics Launches with $6.5M Seed Funding to Tackle Solid Tumors
Key Highlights TwoStep Therapeutics launched with $6.5M seed funding led by NFX. Focus on developing targeted therapies for…
Enlaza Therapeutics Secures $100M in Series A Funding
Key Highlights $100 million Series A funding led by J.P. Morgan Asset Management’s Private Capital. Funding to develop proprietary covalent…
Seismic Therapeutic Secures $121 Million in Series B Funding for Advanced Immunology Drug Development
Key Highlights Seismic Therapeutic, Inc., a machine learning immunology company, announces a $121 million Series B financing, led by Bessemer Venture…
Alto Neuroscience Secures $45 Million in Oversubscribed Series C Financing
Key Highlights Oversubscribed $45 million Series C financing led by InVivium Capital, including new investors like Franklin Templeton and…